| abstract |
An immunogenic composition comprising an antigenic peptide that induces the production of a neutralizing antibody against S100A9 and a carrier protein is provided. The immunogenic composition has an antithrombotic effect, does not involve a long-term bleeding risk, can be used as a highly safe antithrombotic vaccine, and is a disease in which a thrombus involving platelet aggregation is formed. And especially useful for preventing recurrent ischemic stroke. |